![](/img/cover-not-exists.png)
Efficacy and safety of repaglinide added to sitagliptin in Japanese patients with type 2 diabetes: A randomized 24-week open-label clinical trial
Nishimura, Akihiro, Usui, Shuki, Kumashiro, Naoki, Uchino, Hiroshi, Yamato, Azusa, Yasuda, Daijiro, Nagasawa, Kaoru, Okubo, Minoru, Mori, Yasumichi, Hirose, TakahisaYear:
2016
Language:
english
Journal:
Endocrine Journal
DOI:
10.1507/endocrj.ej16-0291
File:
PDF, 737 KB
english, 2016